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B. PE NCAPAIAN PROJEK: 
(Sila tandakan [I] pada kotak yang bersesuaian dan ierangkan secara ringkas eli dalam ruang 
di lwwah ini. Sekiranya perlu. sila gunakcm kertas yang herasingan) 
Penernuan asli/ peningka tan pengetahuan 
We have met the objecti ve of the project wh ich is to determ ine the presence o r· point mutations 
in pat ien ts a ffec ted w ith congen ital adrena l hyperplasia . 
Rekaa n atau perkernbangan produk baru, 
. t.<;i/u hl.!ri fH:njelo.wnl nwklunwn agar mudah dikumputerkun) 
( I) Tiada 
i\'lcnaemba noka n IJroses ata u teknik baru , 
I:' I:' 
(Silo hai j)(.!J?jelasanl /1/akluntcm agar nwdo!t dikomputerkun) 
( 1) Gen SR Y (Sahagian Seks Kromosom Y) : Ia mcn<.:11lukan pembcntukan testi s yang 
ber lokas i di lengan pendek pada kromosom '( . 
(~ ) A llele Specitic O l igonucleotide H: brid izntion lASOH l: Ia merupakan salah satu kaedah 
untuk mengesan mutasi dalam pen: a kit C AH . 
~· 
Gen WNT-4 : lanya sebahagian dari f'ami l i \\ 'NT . 1-'ung.sin: a berlawanan dengan gen 
SRY d i mana ia memainkan pcn111an menga" al pcmlk'llluk<~ n jantina pcrempuan dan 
memghalnng p..:mbentukan testi s. 
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Mcmperbaiki/mcningkatkan produk/proscs/tcl<nik yang scuia ada 
(Sila beri penjelascmlmakluman agar mudah dikomputerkcm) 
(I) menggunakan teknikal Jmng Lelah sedia ada dengan sedikit modify 
Memperbaiki dalam teknik sitogenetik. 
C. PEMINDAHAN TEKNOLOGI 
Be1jaya memindahkan teknologi. 
Klien: Tiada 
(1\):atakan nama penerima pemindahan 
teknologi ini dan sama ada daripada 
pilwk swasta ataupun sector awam) 
13erpotensi untuk pemindahan teknologi: Tiaclo 
(.\l·atakanjenis klien yang mungkin benninat) 
Berpotensi untuk pem indahan teknologi: Tiwlu 
(.\ratakanjenis klien yang mzmgkin hermilwl) 
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D. KOMERS IALISASI 
Berj aya dikomersialkan . 
Tiada 
Nc1111a K I icn : 
Tioda 
Berpotensi untuk cli komers ialkan. 
(:Vyatakanjenis klien yang lllllngkin henninot) 
Tiada 
E. PERKHIDMATAN P ERUN DINGAN BERBANGKIT DARIPADA PROJEK 
(Kiien danjenis perunclingan) 
C l inical services offered to patients" ith ambiguous genita l ia. in patients confirmed as 
congenital adrenal hyperplas ia and surgical correct ion. In CAH cases. counse ling sen·icc "as 
provided in terms o t· se.\: assignment or reass ignment. 
F. PATEN/SIJlL INOVASI UTlLIT I 
(.\l'Oiukon 11V111hor dun toriklifiL'I/d(!/iurciiiJIUten. Sekimn.m purensijil ino,·usi uriliri relu/1 
dipohon te!api 11/0SiiJ beltllll cliclu/iurkun silo haikun 1'1011/hor clontorikh j(Ji! fiUf«:ll) . 
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G. PENERBITAN HASIL DARIPADA PROJEK 
i) PEMBENTANGAN 01 PERSIDANGAN ATAU SEMINAR 
1) First A SEAN Conference on Medical Sciences, 18-21 May 200 I at Renaissance Hotel, Kota 
Bharu, Kelantan. Poster presentation · 
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Muhamad. Fuziah MZ, Rus Anida A, M.R. Sidek, S.F. Fatimah Ramli, N.A. Adam, M.N. lsa. 
2) 13th National Biotechnology Scm inar. I 0-13th November 200 I, Bayview llotcl. Penang. 
Poster presentation. 
Detection of Point Mutation (Pro30Leu) in Exon I of the 21-hydroxylase gene (CY P21) in 
patient with congenital adena! hyperplasia using digoxigenin system. 
Y.K. Muhamad, Fuziah !viZ, Rus Anida A, tvl.R. Sidek, S.F. Fatimah Ramli, N.A. Adam. M.N. 
Is a. 
3) 41st Annual European Society tor Paediatric Endocrinology Meeting. Madrid. Spain on 25-
28th September 2002. 
Molecular Analysis of CY P21 Gene in Patients Presenting \.vith Ambiguous Genitalia. Poster 
presentation. . . . . 
Fuziah MZ. Y. K. rvtuharnad. us /uucla A, ivl. Ft S1clek, S. F. Fatnnah Rami!, M. N. I sa. 
4) 4111 HUGO Pacific ivleeting and 5th Asia Pacil"ic Conference on Human Genetics at Pattaya~ 
Thailand on 27-30th October 2002. · 
Mutations of Pro30Leu and Val281 Leu of the CY P21 gene in patients diagnosed ,, ith 
ambiguous gen ita I ia. . 
M.N. Isa. Y.K. fvluhamad. Fuziah iviZ. Rus An1da A. M.R. Sidek, S.F. Fatimah Ramli. 
ii) PENERBITAN SAINTIFIK 
1) first ASEAN Confer~nce on i'vledical Sciences, 18-21 May 200 I at Renaissance Hotel. l<ota 
Bharu, Kelantan. Poster presentation 
Molecular Analysis in Gender Assignment and Management of Ambiguous Genitalia. y. K. 
rvtuhamad. Fuziah rvJZ. Rus Anida A. IVt.R. Sidek. S.F. Fatimah Ramli. N.A. Adam. tvt.N. lsa. 
-,) 1 ) 111 National Biot~chllL)IO~' Seminar. I 0-13th November 200 I. BaYview HL)t•·~J 1),., 11 . , 
- - -· · ~ · ~ .lllL. 
Poster pres~ntation. -
Detection of Point ~Juration ( Pro30Leu) .in E~on '·of t~1e 2 _!-hydroxylase gene t c y P2 1 ) in 
patient w·ith congen llal ac.:knal hyperplasia usmg d 1gox1genm S) stem. 
Y.K. tvluhamad. Fuziah \'17. Rus Anida A. r'v'I.R. Sidek. S.F. Fatimah Ramli. N.A. Adam rvLN. 
+- • 
I sa. 
1) 41st t.\nnual EurL)p~an SL)I.."i~t\ ror PacdiatriL Fndocrinolou\' fVIeetinn Madi"I'L.J s· . . ....,, 
_, I • ;:._ ::-• ' .1. P·llll l111 --·-
28th September 2002. 
Molecular /-\nnlysis ofCYJ>~ I (~ene in Pati~nts··.Presenting with Ambiouous Ge11 ·11 .11 ·. I> . . 
. .. :::- ~ ' 1.1. tblcl 
presentatiOn. . . . . .. 
Fuziah IVIL. \ .k. fvluh•lmad. us An1da A. rvi.R. S1Lkk. S.F. Fatimah Ramli. rvi.N. ls~ 1 
PublicatiL)Jl : Hornwi~L'. RL'SL'.arcll ~.oo~ 58 {suppl ~) 1-197 (int~rnaliL1nal .lournaiD!' · 
E:\perimcnl~ll ~uH..i ClllliL·all·llLhx:ruwlog~) J>l-160. p 48. ISSN: 0301-0163 
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4) 4111 HUGO Pacific Meeting and 5111 Asia Pacific Conference on Human Genetics at Pattaya, 
Thailand on 27-30th October 2002 . 
Mutations of Pro30Leu and Val281 Leu of the CYP2 I gene in patients diagnosed with 
ambiguous genitalia. 
M.N. Isa, Y.K. Muhamad, Fuziah MZ, Rus Anida A, M.R. Sidek, S.F. Fatimah Ramli. 
Publication : Poster DY 16, Abstract Book 4th HUGO Pacific Meeting and 5111 Asia Pacific 
Conference on Human Genetics. ISBN : 974-05-0173-7 
I 
5) Molecular analysis in the management of congenital adrenal hyperplasia (C/\l-1) and 
ambiguous genitalia. M.N. lsa. Y.K. Muhamad. Fuziah MZ. Rus 1\nida 1\, M.R. Sidek. S.F. 
Fatimah Ramli. Journal of Asean Federation of Endocrine Societies, Vol. 20, 1/2, .Jan/Jul 2002, 
p 12-18. ISSN 0857-1074 
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1. Pusat Pengajian/Pusat/Unit: Pusat Pengajian Sains Perubatan 
1. Tajuk Projek: 
.\/olecular detection q{genetic deji:cts intllllhi~twlls genituliu f.·IGJ am/ congeniwl odrenul 
h_tyn'qJ!asia (CAH) due to 21-l~rclro.\y/use dL~/icienc.y. 
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4. (a) Pcncmuan Projck/Abstrak 
ABSTRACT 
(Perlu disediakan makluman diantara I 00-200 perkataan di dalam Bahasa Malaysia 
dan Bahasa lnggeris, ini kernudicmnya akan dimuatkan ke dalam Laporan Tahuncm 
Bahagian Penyelidikan & f>embangunan sehagai satu cara untuk menyampaikan 
dapatan projek tuanlpuan kepada pihak ()_niversiti.) 
Congenital adrenal hyperplasia (CAH) is a group of inherited disorders affecting the enzymes 
catalyzing the synthesis of steroids in the adrenal cortex. rvtal function of 21-hydroxylase is the most 
ti·equent defect among these disorders. This enzyme is essential· for the synthesis of cortisol and 
aldosterone. The decreased level of serum cortisol in patients with 21-hydroxylase cleticiency 
stimulates ACTH secretion, which result in elevated levels of steroid precursors as 17-
hydroxyprogesterone and increased production of adrenal androgens causing virilization. 
Deficiency of the 2 I -hydroxylase (21-0H) enzyme is by far the most common form of CA H which 
arises as a result of deletions or deleterious mutations in the active gene (CYP21) located on 
chromosome 6p21.3. Many different mutations of the CY P21 gene cause varying degrees or 
impairment of 21-0H activity that results in a spectrum of disease statement. There is no sharp limit 
between the salt- wasting, the simple virilizing and the late onset forms. 
The objective of our study was to determine the 21-0H deticiency mutation defects and correlate the 
genotype with their phenotypic statement of the disease. 
vVe performed mutational analysis using Polymerase Chain Reaction-Allele Specific Oligonucleotide 
Hybridization (PCR-ASOH) technique on patients" ho "·en~ SLJSpected to have CAH as they presented 
"ith ambiguous gen ita I ia (AG) and or electrolyte derangement. 
Among the 52 patients, 3 had Val281 Leu mutation (5.76°·(!). 2 had Pro30Leu mutation (3.85o/o). 1 had 
Gln318stnp mutation ( 1.92o/o) and in 46 (88.-l6uo) pati~nts Ill) 111utation was dete~ted. 
The three patients \Vith Val281 Leu mutation had pr~senh:d "ith ad rena I crises during in t~1 ncy and "as 
dassilied as salt losers and treated with glu~ocorticL)ids and mineralocorticoids. These 3 patients ~ould 
"ell be the other 40o/o who are categorized as sal t-IL)s~rs. The t '' L) patients with Pro30Leu mutations 
han: normal male external genitalia and pres~nt~d '' ith hyponatraemia and hyperkalaem.ia. OnlY one 
. ._, . 
p~~Jicnt required mineralocorticoid therap) that ''as gi\'en for abLHil 5 months duration. Subsequent!~ 
he h~ld norma 1 electrolytes level even without m in~raiL)CL)rl kL)id therapy. The G ln3 I 8stop mutation 
"as id~nt i t·ied in one patient who presented '' ith ambi_~lll)liS g~nitalia and adrenal crises. 
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Our study showed that the cases with genotype Val281 Leu, Pro30Leu and Gln318stop mutations 
correlated with their phenotype. The mutation analysis of CYP21 gene proved to be a good 
complementary investigation and supportive to the diagnosis and management of our CAH patients. 
ABSTRAK 
Hiperplasia adrenal kongenital (C A 1-1) merupakan kumpulan pen yak it warisan yang mcli batkan enzim 
mengkatalase sintesis steroid pada korteks adrenal. Ketakfungsian enzim 21-hidroksilase adalah 
merupakan kecacatan yang sering berlaku berbanding dengan enzim-enzim lain dalam masalah ini. 
Enzim ini penting untuk sinLesis kortisol dan aldosteron. Akibat kekurangan harmon kortisol. 
perangsangan sekresi ACTH terjadi dan ini menyebabkan peningkatan paras precursor steroid seperti 
17-hidroksiprogesteron dan produk androgen adrenal dan te1jadinya virilisasi. Kekurangan ·enzim 21-
hidroksilase merupakan penyebab utama dalam hiperplasia adrenal kongenital yang te1jadi dari tklctan 
dan mutasi gen aktif(CYP21) di kromosorn 6p21.3. 
Terdapat beberapa perbezaan mutasi pada gen CYP21 yang mengakibatkan kepelbagaian da1jah 
kecosakan aktiviti enzim 21-hidroksilase mengakibatkan spectrum pada penyakit. Disini tiacla batasan 
yang tepat antara -~salt wasting·:. ~·simple virilising·~ dan .. late onset form ... 
Objekti f kaj ian in i adalah bagi menentukan jen is mutasi akibat kekurangan enzim 21-h idroksi lase dan 
untuk melihat hubung kait antara genotip dan fenotip. 
Kam i menjalankan anal isis muras i mt!nggunakan kaedah reaksi berantai polymeras~-h ibricl isasi 
oligonukleotid spesifik aiel (PCR-ASOH) pada pesakit yang mempunyai masalah keraguan jantina 
(AG) dan a tau pun hi ponatracm ia dan h iperkalaem ia. l'vlert!ka d ianggap mempun) ai h ip~rplasia 
adrenal knngcniLal. i\lutasi Vai~S I Leu dan Pro30Lcu menyebabkan kadar aktiviti cnzim antara ~0-
60~10 dari kadar normal. Kedua-duanya dikaitkan dengan .. non classical CAH ... 
Mutasi Gln318stop dikategorikan sebagai .. salt \\asting ... Dikalangan 5~ samp~l darah pl'sakit. 3 Llrang 
mengalami mutasi Val281 Leu. ~ orang mutasi Pro30Leu dan seornng mutasi Gln31 Sst .. '-)P scmcntara 
tidak ada mutasi dikesan dalam 46 samp~l. 
/ 
Tiga orang pesakit dengan murasi Va1281 Leu men~1lami adrenal krisis semasa peringk~H bayi dan 
dikategorikan sebagai .. sa It k)~~r ... Mcn:ka mcnerima rawatan ~ glukoknrt ikoid dan m i ncr~\ l~.)kl)rl i kl'~id. 
Ketina-tioa p~sakit ini lllUIH!kin lll~\\akili -l0°·u J1csakit \Hng dikatcgorikan s~l1: 1 o· 11· ··~··til ,, .. 1. •• :::::- :::::- • - · ... - · • ::-~ ·'' ,Is 111g . 
Dua ornn" pL'S~lkit dcn!.!all mut~1si PrL)30Lc·u llll'lllpun' ai janrina ekstcrnal klaki ,··111 u lllli'Jll·tl 1. 1 1. :=- - • • .~ ::- • 1..111 lallr 
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dengan hiponatraem ia dan hiperkalaem ia. Hanya seorang pesakit sahaja yang memerlukan terapi 
mineralokortikoid di mana rawatan ini telah diberi~an dalam jangka waktu 5 bulan. Berikutnya. 
pesakit itu mempunyai paras elektrolit yang normal tanpa terapi mineralokortikoid. Mutasi 
Gln318stop telah dikcnalpasti berlaku dikalangan pes~kit yang mengalami keraguan jantina dan krisis 
adrenal. 
Kajian ini menunjukkan bahawa pesakit-pesakit yang mempunyai gcnotip Val281 Leu. Pro301eu dan· 
Gln318stop mempunyai korelasi yang berhubungkait dengan fenoLip. Anal isis muLasi pada gen CYP21 
merupakan satu kaj ian yang san gat baik dan membantu diagnosis dan pcngurusan pesakit hiperplasia 
adrenal kongenital. 
(b) Scnaraikan Kata Kunci yang digunakan di dalam abstntk: 
Bahasa i\llalavsia 
Htj;erp/asiu Adrenal Kongenital 
Gen CYP21 
K·enwuan .!an/ina ~ .... 
Penentuan seks(.)R }) 
Bahasa lnggcris 
Congenital Adrenoll(tjJC!fJJiosia (( 'Afl; 
C}'P21 gene 
A mhiguuus Genii alia (A GJ 
Sex Determine/lion Region-}' (.)'RY;. 
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5. Output Dan Faedah Projek 
(a) Pcncrbitan (termasuk laporan/kertas seminar) 
(Sila nyatakan jenis, tajuk, pengarang, tahun terbitan dan di mana telah diterbitkan/dibentangkan) 
I) first A SEAN Conference on Medical Sciences, I 8-2 I May 200 I at Renaissance Hotel, Kota 
Bharu, Kelantan. Poster presentation. Molecular Analysis in Gender Assignment and 
Management of Ambiguous Genitalia. Y.K. Muhamad, Fuziah MZ, Rus An ida A, M.R. 
Sidek. S.F. Fatimah Ramli, N.A. Adam. M.N. lsa. Poster dilampirkan. 
2) I 3111 National Biotechnology Seminar, I 0- I 3th November 200 I, Bayvie\v Hotel, Penang. 
Poster presentation. 
Detection of Point Mutation (Pro30Leu) in Exon I of the 21-hydroxylase gene (CYP21) in 
patient with congenital adena! hyperplasia using digoxigenin system. Poster dilampirkan. 
Y.K. Muhamad, Fuziah MZ, Rus Anida A, M.R. Sidek. S.F. Fatimah Ramli, N.A. Adam, M.N. 
I sa. Poster dilampirkan. 
3) 41st Annual European Society for Paediatric Endocrinology rvfeeting, Madrid, Spain on 25-
28th September 2002. 
rvlolecular Analysis of CY P21 Gene in Patients Presenting \.vith Ambiguous Genitalia. Poster 
presentation. 
fuziah MZ, Y.K. Muhamad, us Anida A. ~'I.R. Sidek. S.F. Fatimah Ramli~ M.N. lsa. 
Publication : Hormone Research 2002 58 (suppJ 2) 1-197 (international Journal of 
Experimental and Clinical Endocrinology) P 1-160. p 48. ISSN : 0301-0163. 
Poster dilampirkan. 
4) 4111 HUGO Pacific l\.1eeting and 5111 Asia Pacific Conl~rence on 1-luman Genetics at Pattaya. 
Thai land on 27-30th October 2002. 
Mutations of Pro30Leu and Val281 Leu of the CYP21 gene in patients diagnosed with 
ambiguous gen ita I ia. 
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Introduction: 
CAH due to 21-(0H) deficiency : 
.;. Group of recessively inherited diseases 
4o More than 95% of all cases of CAH 
4o CAH exist in a very wide severity : 
i. Salt Wasting 
ii. Simple Virilizing 
iii. Non Classical 
} Classical 
.;. Incidence 1: 10,000-17,000 in Western Europe & USA. 
World wide 1: 14,000 births . 
Adrenal and Gonadal Steroidogenesis 
Cholesterol 
~ .. ,._ .. ,_ 
· .... ,· .. -..... . 
•f( 
:·;: ,1{\f; 
Pregnenolone .. 1 i -OH Prr:gncnolonc DHEA • Androstencd•ol 
··: li'.:. ~ ' ... -.J, i .. :; ,,,:.! 
:. '""·'' ... ;.... .j. : • . :·· !. ... ; •;; /1\il 
... ~---2LQ.u_nster(J"c ~ ~'J...OH.P.r..?gestcrone ~Androstenedione ~ Testosto•·onc ( ..... )! (· .. :. · ... ) , .. ,.,,...... , ........ ,_ .. 
----- .. ---·-·· ___ ..... ~ + 
..... __ , 
Dc:ol(yl;ortccostcrone 11-0coxycortisol Oc:stronCJ . ·:• ,,1 , Oestradiol 
.. . ... ! ... . ... l 
Corticosterone Cortisol 
! 
tll-OH Conicost'-'rone ! ., ,,,, ··'·· :· 
Aldosterono 
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CAH due to 21-(0H) deficiency: 
"' Arises as a result of deletions or 
deleterious mutations in the active gene 
(CYP21) located on chromosome 6p . 
• Many different mutations of the CYP21 
gene have been identified causing varying 
degrees of impairment of 21-hydroxylase 
activity that result in a spectrum of 
disease expression. 
Introduction: Clinical Picture . 
i. Sa(t Wasting 
• The most severe form of CAH 
• Salt wasting crisis in the first 2 weeks of life 
• First sign of the disease: 
Girls - born with ambiguous genitalia 
Boys- hypovolemia, acidosis, hyponatremia, and 
hyperkalemia (adrenal crisis) 
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Introduction: Clinical Picture 
ii. Simpfe o/irifizing 
-t- Diagnosed as virilization at 3-7 yr 
.;. Female - pubic hair. phallic enlargement, increase 
muscle mass. and advanced bone age. 
Boys - testicular size remains pre pubertal in CAH but 
increases in central precocious puberty. 
Introduction: Clinical Picture 
iii. Won C{assica( 
• The mild NC form of 21-0HD. 
• Females - diagnosed at or after adolescene 
- present with hirsutism. acne, 
irregular menses. infertility 
• Male - not recognized. 
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"' Phenotype graded according 
to clinical severity 
r -- . 
OBJECTIVE: 
.. : . . 
. . 
:· '1' 
• To determine the presence of point mutations in 
patients affected with congenital adrenal 
hyperplasia 
,. 
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Genotype and Phenotype Relationships 
"" CYP21 mutations can be grouped into 3 categories according to 
enzyme activity 
"" The relationship between genotype and phenotype in the common 
mutation of the CYP21 gene. 
Genotype Phenotype Activity enzyme 
(%) 
Arg 356Trp + Salt wasting 
.±2 
Gin 318Stop 
llei172Asn Simple virilizing 18.±9 
Pro30Leu 
Val281 Leu Non-classic 30-60 
Normal 
Genotyping can be used to predict the .degree of 
disease severity patients affected with CAH 
a.P30L 
• The mutations in exon 1 
"'" C.QG (Proline) ~ to C!G (Leucine) 
"'"Associated with nonclassical 21-hydroxylase deficiency 
5 
I 
I 
I 
I 
II 
II 
I 
I 
I 
' II 
' 
' II~ 
I ., 
'i 
' I' 
I 
b.V281L 
.r. The mutations in exon 7 
.r. A change in codon 281 from 
GTG (Valine) ~ TTG (Leucine) 
.r. The codon 281 mutation is associated 
with nonclassical 21-hydroxylase 
deficiency 
c. Q318X 
.r. The mutations in exon 8 
.r. Codon 318 in this gene is changed from 
CAG (glutamine)~ TAG stop codon 
.;, The codon 318 mutation is associated 
with salt wasting form in CAH 
.... - -. .., -, -· ",,· ~ .. 
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A 2 3 4 5 6 7 8 9 10 
-
I • II I • .I • I I. - II Nonclassic P30L V281 L 
Simple virilizing 11 72N 
Salt wasting R356W 
F306+ lnt Q31P'l( 
8 
::. c: 
Exons 
1-3,3-7 
Exons ::. c: 
6-10 
1 kb 
Schematic representation of 21-hydroxylase deficiency (CYP21) gene 
structure and location of the common mutatoons of the gene. The numbers 
outside the box indicate exon number. 
METHODS 
Blood samples were obtained from patients re ferred to Hospital Universiri 
Sains Malaysia, Kclantan, Malays1a durifiQ 1995-2002. A thorough clinical 
ex amination and hormonal analyses were performed. A 16 tal of 52 
samples included patients with external genitalia or electrolyte 
L_ ____ _____ _ _ _ ...twb.al.lnccs 
DNA extraction (non-phenol chloroform 
standard procedure I 
r. 
Polymerase Chain Reaction (PCRI 
PCR·ASOH (Allele Specific Oligonucleotide 
Hybridization) mutational analysis using PCR· 
ASOH technique 
D 
I DNA sequencing 
. ;''1 
./I . . 
.I . \ _...., . 
! .. 
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1000 bp 
800 bp 
SOObp 
RESULTS 
Figure 1: Presence of PCR product for CYP21 gene 
exon 1·3 using 2.0% agarose gel electrophores is. 
Lane M : 100 bp. DNA ladder, lane N : negative control, 
lane 1: normal samples, lane 2-6 : samples showing 
PCR amplification products for CYP21 gene. 
RESULTS 
1000 bp 
800 bp 
500 bp 
Figure 2: Presence of PCR product for CYP21 gene 
exon 4-7 using 2.0% agarose gel electrophoresis. Lane M : 
100 bp. DNA ladder. lane 1 : negative control. lane 2 : 
normal samples , lane 3.4.5.6.7 . samples showing PCR 
amplification products for CYP21 gene . 
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RESULTS: 
4 
N 0 
p • 
Figure 3: Dot blotting was performed using 1 1.1g genomic DNA. The blot 
was hybridized with 100 pmol/ml of the digoxigenin labeled 
antiphosphatase (DIG-AP) specific probe from samples of patient 1-7. 
ASOH of PCR product from CAH patients was performed with the 
probe V281 L corresponding to the site exon. The status N: normal, P: 
patient. 
RESULTS 
3 4 
N ~ •tr ., 0 p 
~·~ 6 
Figure 4: Pro30Leu hybridization DNA samples. Dot blotting was 
performed using 1 1.1g genomic DNA. The blot was hybridized with 
100 pmol/ml of the digoxigenin labeled antiphosphatase {DIG-AP) 
specific probe Pro30Leu. ASOH of PCR product from CAH patients 
was performed with the probe (Pro30Leu) corresponding to the site 
exon 1. The status N: normal, P: patient. 
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RESULTS 
4 
N G 4 . ·~;':Q •:o· ? 
p 
Figure 5: Q318X hybridization DNA samples. Dot blotting was 
performed using 1 J,Jg genomic DNA. The blot was hybridized with 1 00 
pmol/ml of the digoxigenin labeled antiphosphatase (DIG-AP) specific 
probe Q318X. ASOH of PCR product from CAH patients was 
performed with the probe Q318X corresponding to the site exon 8. 
The status N: normal, P: patient. 
RESULTS 
Table 1 : Identified mutations in samples analysed 
Ex on Codon Nucleotide Amino acid No. of 
alteration changes samples 
1 30 C~G--CIG Proline- 2 
Leusine 
7 281 CQT--CIT Valine- 3 
Leusine 
8 318 G~A-GIA Glutamin-- 1 
Stop codon 
· .. ~: .. .,, 
·. . . ~ . 
.... ,.· ·:. -·s : -~ 
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RESULTS 
R356W 
O% \ llc172N 
0% 
FJ06+t 
Q318stop }_____-- 0% 
H%_51·:· ,..}~,_ProJOiou 
33% 
Val2811eu - · 
50% • 
Figure 6 : A pie chart showing percentage of CYP21 gene 
mutation according to each exon . 
RESULTS 
Table 2: Frequency of CYP21 gene mutation in patients diagnosed 
with congenital adrenal hyperplasia (CAH). 
Diagnosis of CAH Mutation Percentage (%) 
Pro30Leu 2/52 I 3.85 
Vai281Leu 3/52 5.77 
Q318Stop 1/52 1.92 
TOTAL 6/52 11.54 
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Figure 7 : A pie chart showing percentage of frequency for CYP21 
gene mutation in patients diagnosed with CAH. 
RESULTS 
Table 3: Relations between genotype & 
phenotype 
Genotype Salt Simple Non-
wasting virilizing classical 
(SW) (SV) (NC) 
Pro30Leu 0 0 2 
Vai281Leu 3 0 0 
Q318stop 1 0 0 
Total 4 (66.67%) 0 2 (33.33%) 
··~· . a I. 
PlOL • I e 
OJ18X I? 
~ SW SV riC 
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China 
:Chile 
Frequency of common mutations 
among 21-hydroxylase deficiency alleles in different populations 
40 
126 
28 
7 
8 10 
9 11 
..... ---·--
i Mexico 94 . 9 12 9 . 4 7 1 
r::---:: ---·-- ... ---------·-------·-·---·-·· ··-·· -- --·····--!------~ 
~~(~-------- --;··----~~ ---·----·. 19 4 _,~--. -: -----~-- __ ; 
:_~!9~~t~~~-------- .J. _______ !!_ __ .. -- . - . . -... ~~ ---·- ·-. ~ ..... - . . .. ~-4 -· -····-- --~ ····--~ 
CONCLUSION 
"" Some variability in clinical expression can occasionally be seen 
among patients with the same genotype but in the majority of 
cases good relationships between CYP21 genotype and CAH 
phenotype are found. 
"" Therefore we find genotyping of CYP21 to be very useful for 
prediction of clinical outcome in CAH patients. 
• The possibility to predict disease outcome in CAH patients by 
mutations analyses has had several implications for treatment. 
• Our findings showed that patients with Pro30Leu mutations were 
associated with non-classical form of CAH whereas Val281 Leu 
mutations were associated with salt wasting form of CAH. 
13 
" I 
I 
I 
I 
II 
II 
.. 
• 
I 
I 
I 
;.. .. r .. 
.:,. ·~--· ~· :·~·~;~-:;r·~-~v::.::r.·:~-·~:1·-~j~;:.~; 
PRESENTATION I PUBLICATION 
1) Molecular Analysis of CYP21 Gene in Patients Presenting with Ambiguous 
Genitalia. MZ Fuziah, KM Yulia, A Rus Anida, MR Sidek, SF Ramli SF, MN lsa. Poster 
presentation at European Society for Paediatric Endocrinology 4 1'1 Annual Meeting, 
Madrid on 25-28 September 2002. 
Publication : Hormone Research 2002, 58 (suppl 2}: 1-197 (International Journal of 
Experimental and Clinical Endocrinology) P1-160, page 48. 
ISSN 0301-0163 
2} Mutations of Pro30Leu and Val281 Leu of the CYP21 Gene in Patients Diagnosed 
with Ambiguous Genitalia. 
MN lsa, Y.K. MLihamad, Fuziah MZ, Rus Anida A, M. Ros Sidek, S.F. Ramli. 
Poster presentation at 4th HUGO Pacific Meeting and 51h Asia- Pacific Conference on 
Human Genetics on 27-30.10.02 at Pattaya, Thailand. 
Publication : Poster OY 16, abstract book 41h HUGO Pacific Meeting and 51h Asia- Pacific 
Conference on Human Genetics 
ISBN : 974-05-0173-7 
PRESENTATION I PUBLICATION 
3) Molecular Analysis in the Management of Congenital Adrenal Hyperplasia 
{CAH) and Ambiguous Genitalia. 
MN lsa. Y.K. Muhamad. Fuziah MZ. Rus Anisa A, M. Ros Sidek, S.F. Ramli, N. Adam. 
Journal of the Asean Federation of Endocrine Societies, Vol 20, No 1/2, Jan/July 
2002 (12-18). ISSN0857-1074 
4) Detection of Point Mutation (Pro30Leu) in Exon 1 of the 21-hydroxylase 
gene(CYP21) in patient with Congenital Adrenal Hyperplasia using Digoxigenin 
system. 
Y.K. Muhamad, Fuziah MZ. Rus Anda A. M.R. Sidek. S.F.. Ramli. N.A. Adam, M. N. 
tsa. Poster presentation at 13th National Bioatechnology Seminar . 1 0-13th November 
2001. Penang. 
5) Molecular Analysis in Gender Assignment and Management of 
Ambiguous Genitalia. Y.K. Muhamad. Fuziah MZ. Rus Anda A,. M.R. Sidek. S.F., 
Ramli. N.A. Adam, M. N. lsa 
Poster presentation at First Asean Conference On Medical Sciences. , 18-21 May 
2001,Kota Bharu, Kelantan . 
... 
.J 
14 
.d 
d 
II 
d 
II 
d 
II 
International Journal of 
Experimental and 
Clinical Endocrinology 
~. Katgcr 
Medical and SctcntifiL 
Ba;~i • F r<•tbut g 
Pan• · t_,,nol)n 
~l!" Y.;H k · :\c" Ddhi 
llaogk(•~ • Slllg;tpnrc 
li""'lt\o l a '\1d l,•\ 
4 1st Annual Meeting oi the 
European Society for 
Paediatric Endocrinology 
(ESPE) 
l'v1adrid, Spain, 25-28 September, 2002 
Guest Editor: 
Jesus Argente, Madrid (Spain) 
~. . . . . 
. . . . • . . : ····::_· . .-: : . lo . •• 
. :· . . 
. . 
-: . ... . 
. . -· ... . 
::. . . : .: ... 
. ' .. ': ' .. ~ 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
J.... J. 
pre 
ba~ 
P1-160 Poster Session 1 tnv 
MOLECULAR ANALYSIS OF CYP21 GENE IN PATIENTS 
PRESENTING WITH AMBIGUOUS GENITALIA 
F. Md. Zain 1; Y. KM2; R. A3; M .. Sidek2; ·s. Ram/P; M. lsa2 
1Paediatrics, School of Medicine, Health Campus, Universiti Sains 
Malaysia, Kelantan, Malaysia; 2Human Genome Centre, School of 
Medicine, Health Campus, Universiti Sains Malaysia, Kelantan, 
Malaysia; 3Paediatrics, Hospital Kota Bharu, Kelantan, Malaysia 
Introduction: Congenital adrenal hyperplasia (CAH) is a group of autosotnal 
recessive disorders of adrenal steroidogenesis. The genes of the steroidogenic 
enzytnes and the n1utations involved have been described. Deficiency of the 21-
hydroxylase (21-0H) enzyn1c is by far the n1ost con11non fonn of CAH which 
arises as a result of deletions or deleterious n1utations in the active gene (CYP21) 
located on chrotnosotne 6p. Many different n1utations of the CYP2 I gene cause 
varying degrees in itnpainnent of 21-0H activity that results in a spectru1n of 
disease expression. There is no sharp lin1it between the salt-wasting, the siinple 
virilizing and the late onset fonns. Objective: To detennine the 21-0H 
deficiency .. mutation defects and correlate the genotype with their phenotypic 
expression of the disease. Patients/Material and Methods: We performed 
mutational ~nalysis ~s~ng. Polyn1erase Chain Re~ction - Aile]~ Specific 
Oligonucleotide Hybndtzatton (PCR-ASOH) techntque on 6 patients who 
presented wi~h ambiguous geni~alia (AG) and or electrolyte derangement as 
hyponatraemta ~nd hyperk~laem1a, suspe_cted to have CAH. The Val281Leu and 
Pro30Leu mutations result tn enzytnes with 20-60% of normal activity and both 
are associated with the non-classical fonn of CAH. The Gln3 I 8stop Inutation is 
categorized under the salt-wasting type. I~e~ults:_ Atnong the 6 patients, 3 had In~ 
Val28 J Leu tnutation, 2 had Pro30Leu n1utat1on and I had Gln318stop 1nutation. det 
The 3 patients with Val281 Leu n1utation had presented with adrenal crises during Ox 
infaricy and was classified as salt losers and treated with glucocorticoids and ste. 
mineralocorticoids. These 3 patients could weJI be the other 40% who are UIT 
categorized as salt losers. The 2 patients with Pro30Leu tnutations have norn1ai stn 
male external genital.ia and. presented. wi.th hyponatrae~nia and hyperkalaemia. as 1 
Only 1 of thetn requtred nlrncralocorltcotds that w~1s gtven for about 5 months big 
duration. Subsequently he had nonnal electrolytes even without ste 
mineralocorticoid therapy. The Gln318stop tnutation was identified in one the 
patient who presen~ed witl_1 AG and adrenal crises. Conclusions: Our study for 
showed that the patien.ts wit~l genotype Y~l~281 Leu,. Pro30Leu and GlnJl8stop we 
tnutations correlated with their phen~type .. I h~ n1utation analysis of cyp21 gene sol 
proved to be a good complen1enta~·y Investtgatton and supportive to the diagnosis del 
and managetnent of our CAH pat1cnts. ~ he~ 
P1-161 Poster Session 1 
PROPOSAL FOR PRENATAL MANAGEMENT OF 
CONGENITAL ADRENAL HYPERPLASIA (CAH) IN 
EUROPE BASED ON THE EXPECTED NUMBER OF 
ft A "''""I r' II\ 8 T ~ 
011' 
ad\ 
Ui1; 
hyj 
. h. 
J 
bel 
-Ill 
II 
II 
-
• -l 
• 
• -· l 
• - l. 
• l 
" 
' 
' 
' II 
I 
I 
MOLECULAR ANALYSIS of CYP21 GENE in 
PATIENTS PRESENTING with AMBIGUOUS 
GENITALIA 
MZ FUZIAH1, KM YULIA2, A. RUS ANIDA3, MR SIDEI<2, SF 
RAMLI2 MN ISA 4 
' 
1 Department of Paediatrics ,2 Human Genome Centre, School 
of Medicine, USM, 16150 /(ubang /(erian, 3 Department of 
Paediatrics, Hospital J(ota Bharu, Kelantan, 4/nternational 
Medical University, Putrajaya, Malaysia. 
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Congenital afdrednal h
1
yp{!tplasia (CAH) is a group of. .a~\9~~>rf.ta : ·~r~~~~l1:~::~~~~~w~f.:·: \ 
disorders o a· rena s~~roidogenesis. The genes o_f :~he· .,.· i t ........... ~.t ... < l· 
enzymes and the mutations involved have been described. D · .. , · - ~~ .: ' l 
the 21-hydroxylase (21-0H) enzyme is by far the mo~t bq .. . ,: .. . ::{/· h. 
CAH which arises as a result of deletions or deleterious mufat( ·.< :"'- : . ' '-" .. ·: t. 
active gene (CYP21) located on chromosome 6p. Many ·ciitrer~nt ~ 
of the CYP21 gene cause varying degrees of impairment of 21-0H 
that results in a spectrum of disease _expression. There is no sharp ifrrlit 
between the salt- wasting, the simple virilizing and the late onset forms. 
The objective of our study was to determine the 21-0H deficiency mutation 
defects and correlate the genotype with their phenotypic _expression of 
the disease. 
We performed mutational analysis using PCR-ASOH (Polymerase Chain 
Reaction - Allele Specific Oligonucleotide Hybridization) technique on six 
patients who presented with ambiguous genitalia (AG) and or electrolyte 
derangement as hyponatraemia and hyperkalaemia, suspected to have 
CAH. The Val281 Leu and Pro30Leu mutations result in enzymes with 20-
60% of normal activity and both are associated with the non-classical form 
of CAH. The Gln318stop mutation is categorized under the salt-w~-~~-ing 
type. ·.; _.~, ·. 
Among the six patients, three had Val281 Leu mutation, two had Pro30Leu 
mutation and one had Gln318stop mutation. The three patients with 
Val281 Leu mutation had presented with adrenal crises during infancy and 
was classified as salt losers and treated with glucocorticoids and 
mineralocorticoids. These 3 patients could well be the other 40% who are 
categorized as salt-losers. The two patients with Pro30Leu mutations have 
normal male external genitalia and presented with hyponatraemia and 
hyperkalaemia. Only one patient required mineralocorticoid therapy that 
was given for about 5 months duration. Subsequently he had normal 
electrolytes level even without mine~alocorticoid therapy. The Gln318stop 
mutation was identified in one patient who presented with ambiguous 
genitalia and adrenal crises. 
Our study showed that the patients wi~h gen?type Val281 Leu, Pro30Leu 
d GlnJ1Sstop mutations correlated w1th the1r phenotype. The mutation 
an 1 ·s of CYP21 gene proved to be a good complementary investigation =~~ ~~~pportive to the (_tiagn~sis and management of our CAH patient_s. ~ 
. co_ngenital adrenal hyp~rp}asia, c Key words: ari}b1g~_ou,~ . . . . _7 . • : ... · . 
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Ambiguous genitalia (AG) are one of the clinical pres·enta~ions ·of · 
congenital adrenal hyperplasia (CAH). Congenital adren-1 
hyperplasia is an autosomal recessive disease caused by lo!is 
or severe decrease in the activity of 21-hydroxylase (21-0H). 
This· enzyme is one of the five enzymes necessary for cortisol 
biosynthesis. Deficiency of the 21-0H is the most common form 
of CAH accounting for. 90-95% of all cases of CAH1•6 • 
congenital adrenal hyperplasia presents a wide spectrum of 
clinical manifestations and patients are divided in.to 3 groups: 
salt wasting (SW), simple virilizing (SV) and non-classical (NC). 
Salt wasting patients manifest as neonatal electrolyte 
disturbances together with virilization of external genitalia at 
birth in girls and early pseudoprecocious puberty in boys, while 
sv patients present the same manifestation as SW patients, but 
without electrolyte disturbances. Non- classical patients present 
with late onset symptoms of androgen excess, ranging from 
progressive virilization and · pseudoprecocious puberty in 
childhood to menstrual disturbances, infertility and hirsutism in 
adult women~. 
It was reported that more than 90% of cases of CAH are caused 
by mutation of the CYP21 gene. This 21-0H (CYP21) gene is 
located in the HLA class Ill gene region on chromosome 6p21.3 
and consist of 10 exons3• Majority of the mutations on the 
cYP21 gene are Vai281Leu and Pro30Leu. These mutations were 
reported to result in 20-60% of normal enzyme activity and both 
are associated with the non-classical form of CAH4,5• 
To detect the presence of point mutations in Pro30Leu, 
ue172Asn & Vai281Leu of CYP21 gene 
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Figure 1: Presence of PCR product (873 bp) for CYP21 gene 
exon 1-3 using 2.0°/o agarose gel electrophoresis. Lane M : 100 
bp DNA ladder, lane N : negative control, lane 1, 2 : normal 
samples, lane 3,4,5,6 : samples showing PCR amplification 
products for CYP21 gene. 
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Figure 2: Dot blotting was performed using 1 J,Jg genomic DNA. 
The blot was hybridized with 100 pmol/ml of the digoxigenin 
labeled antiphosphatase (DIG-AP) specific probe from samples 
of patient 1-7. ASOH of PCR product from CAH patients was 
performed with the pr~be corresponding to the site exon. The 
status N: normal, P: pat1ent. 
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Figure 3: Pro30Leu hybridization DNA samples. Dot blotting 
was performed using 1 IJg genomic DNA. The blot was 
hybridized with 100 pmol /ml of the digoxigenin labeled 
antiphosphatase (DIG-AP) specific probe Pro30Leu. ASOH of 
peR product from CAH patients was performed with the probe 
(Pro30Leu) corresponding to the site exon 1. The status N: 
normal, P: patient. 
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Majority of the mutations in the CYP21 gene in our 
patients are Val281 Leu and Pro30Leu. These mutations 
were reported to result in 20-60o/o of normal enzyme 
activity and both are associated with the non-classical 
form of CAH4'7• 
In our study, we found that 3/52 patients (5.7°/o) have 
Val281 Leu while 2/52 patients (3.8°/o) have Pro30Leu 
respectively. No mutations were observed ~n lle172Asn. 
Patients with Val281 Leu pres·ented with adrenal crisis 
during infancy and were classified as salt wasting. Two 
patients with Pro30Leu mutations have normal male 
external genitalia and presented with hyponatraemia 
and hyperkalaemia. We did not identify any patient with 
1172N mutation which is known to result in clearly 
reduced enzymatic activity. About 1-2o/o of 11_72N 
mutation is usually associated with the SV form8'9• 
Our findings showed that patients with Pro30Leu 
mutations were associated with non~classical form of 
CAH whereas- Val281 Leu mutations were associated 
with salt wasting form of CAH. 
This study suggested that phenotypes are not always 
concordant with the genotype in patients with 
vat281 Leu mutations diagnosed with CAHo 
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Mutations of Pro30Leu and Val281Leu of the CYP21 Geue in Patients DfagD.ose(fW:iiii' '.A.rQi)iguons .. Genita.iia 
1 Human Genome Centre, 2Departmen:t of Paediat:rics, School of Medicine., USM, .16150 Kllbang Ker~ 
3 Department of Paediatrics, Hospital Kota Bharu., Kelantan, Malaysia. 
Ambiguous Genitalia (AG) is one of the presentations of congenital adrenal hyperplasia (CAH). Congenital adrenal 
hyperplasia is an autosomal recessive disease caused by loss or severe decrease in the activity of 21-hydro"'-"Ylase (2 l-
OH). This enzyme is one of the five enzymes necessary for cortisol biosynthesis. Deficiency of the 21-0H is the most 
common form of CAH accounting for 90-95°/o of all cases of congenital adrenal hyperplasia. Congenital adrenal 
hyperplasia presents a wide spectrum of clinical manifestations and patients are divided into 3 groups: salt v-.·asting 
(SW)~ simple virilizing (SV) and non-classical (NC). Salt Wasting patients manifest neonatal electrolyte disturbances 
together with virilization of external genitalia at birth in girls and early pseudoprecocious puberty in boys. \\'hile SV 
patients present the same manifestation as SW patients.. but '\vithout electrol}'te distutban~. Non-classical patients 
present with late onset symptoms of androgen excess, .ranging from progressive virilization and pseudoprecocious 
puberty in childhood to mensnual disturbances~ infertility and hirsutism in adult l\,omen. It V.'as reported that more 
than 90% of cases of CAH are caused by mutation of the CYP2l gene. This steroid 21-0H (CYP21) gene is located in 
the HLA class ill gene region on chromosome 6p21.3 and consist of 10 exons. Majority of the mutations on the 
CYP21 gene are Val281Leu and Pro30Leu.. These mutations -were reported to result in 20-60o/o of normal enzyme 
activity and both are associated \\ith the non-classical form of CAR. Our aim of the study is to detect the presence of 
point mutations in Pro30Len~ llel72Asn and Val28lLeu of CYP21 gene. We have performed PCR-ASOH technique 
on 52 patients with ambiguous genitalia (AG). They presented with AG in Hospital Universiti Sains Malaysia & 
Hospital Kota Bharu, Kelantan Malaysia. We found that 3 out of 52 patients (5. 7%} were having Val28lLeu and 2 out 
of 52 patients (3.8%) afPro30Leu respectively. No mutations were obseiVed in llel72Asn. Patients with Val281Leu 
presented with adrenal crisis during infancy and were classified as salt wasting. Two patients with Pro30Leu 
mutations have normal male external genitalia and presented with hyponatraemia and hyperkalaemia. Our findings 
showed that patients with Pro30Leu mutations were associated with non-<:lassical fonn of CAR.., whereas Val281Leu 
mutations we~ associated with salt wasting form of CAR. 11ds study suggested that phenotypes are not always 
concordant wtth the genotype in patients with Val281Leu mutations diagnosed with CAH. 
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MUTATIONS OF Pro30Leu AND Val281Leu OF 
THE CYP21 GENE IN PATIENTS DIAGNOSED 
WITH AMBIGUOUS GENITALIA 
M.N.Isa4, Y.K.Muhamad1, Fuziah MZ2, R~s Anida A3,M.Ros 
Sidek1, S.F .Ramli1 
1 Human Genome Centre, 2 Department of Paediatrics, School of 
Medicine, USM, 16150 J(ubang J(erian, 3 Department of 
Paediatrics, Hospital Kota Bharu, /(elantan, 4/nternational 
Medical University, Putrajaya, Malaysia . 
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ABSTRACT 
Congenital adrenal hyperplasia (CAH) is .a group of autosomal recessive 
disorders of adrenal steroidogenesis. The genes of the steroidogenic 
enzymes and the mutations involved have been described. Deficiency of 
the 21-hydroxylase (21-0H) enzyme is by far the most common form of 
CAH which arises as a result of deletions or deleterious mutations in the 
active gene (CYP21) located on chromosome 6p. Many different mutations 
of the CYP21 gene cause varying degrees of impairment of 21-0H activity 
that results in a spectrum of disease expression .. There is no sharp limit 
between the salt- wasting, the simple virilizing and the late onset forms. 
The objective of our study was to determine the 21-0H deficiency mutation 
defects and correlate the genotype with their phenotypic expression of the 
disease. 
We performed mutational analysis using PCR-ASOH (Polymerase Chain 
Reaction - Allele Specific Oligonucleotide Hybridization) technique on six 
patients who presented with ambiguous genitalia (AG) and or electrolyte 
derangement as hyponatraemia and hyperkalaemia, suspected to have 
CAH. The Val281 Leu and Pro30Leu mutations result in enzymes with 20-
600/o of normal activity and both are associated with the non-classi~al form 
of CAH. The Gln318stop mutation is categorized under the salt-wasting 
type. 
Among the six patients, three had Val281 Leu mutation, two had Pro30Leu 
mutation and one had Gln318stop mutation. The ttiree patients with 
Val281 Leu mutation had presented with adrenal crises during infancy and 
was classified as salt losers and treated with glucocorticoids and 
mineralocorticoids. These 3 patients could well be the other 40°/0 who are 
categorized as salt-losers. The two patients with Pro30Leu mutations have 
normal male external genitalia and presented with hyponatraemia and 
hyperkalaemia. Only one patient required mineralocorticoid therapy that 
was given for about 5 month.~ duration. Subsequently he had normal 
electrolytes level even without mineralocorticoid therapy. The Gln318stop 
mutation was identified in one patient who presented with ambiguous 
genitalia and adrenal crises. 
our study showed that the patients with genotype Val281 Leu, Pro30Leu 
and Gln318stop mutations correlated with their phenotype. The mutation 
analysis of CYP21 gene proved to be a good complementary investigation 
and supportive to the diagnosis and management of our CAH patients. 
Key words: ambiguous genitalia, congenital adrenal hyperplasia, CYP21 
gene. 
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INTRODUCTION 
Ambiguous genitalia (AG) are one of the clinical presentations of 
congenital adrenal hyperplasia (CAH). Congenital adrenal 
hyperplasia is an autosomal recessive disease caused by loss 
or severe decrease in the activity of 21-hydroxylase (21-0H). 
This enzyme is one of the five enzymes necessary for cortisol 
biosynthesis. Deficiency of the 21-0H is the most common form 
of CAH accounting for 90-95°/o of all.cases of CAH1'6• 
Congenital adrenal hyperplasia presents a wide spectrum of 
clinical manifestations and patients are divided into 3 groups: 
salt wasting (SW), simple virilizing (SV) and non-classical (NC). 
Salt wasting patients manifest as neonatal electrolyte 
disturbances together with virilization of external genitalia at 
birth in girls and early pseudoprecocious puberty in boys, while 
SV patients present the same manifestation as SW patients, but 
without electrolyte disturbances. Non- classical patients present 
with late onset symptoms of androgen excess, ranging from 
progressive virilization and pseudoprecocious puberty in 
childhood to menstrual disturbances, infertility and hirsutism in 
adult women2• 
It was reported that more than 90°/o of cases of CAH are caused 
by mutation of the CYP21 gene. This· 21-0H (CYP21) gene is 
located in the HLA class Ill gene region on chromosome 6p21.3 
and consist of 10 exons3• Majority of the mutations on the 
CYP21 gene are ·Val281 Leu and Pro30Leu. These mutations were 
reported to result in 20-60°/o of normal enzyme activity and both 
are associated with the non-classical form of CAH4'5• 
AIM OF THE STUDY 
To detect the presence of point mutations 1n Pro30Leu, 
lle172Asn & Val281 Leu of CYP21 gene 
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MATERIALS AND METHODS 
Blood samples were obtained from patients referred to Hospital 
Universiti Sains Malaysia , Kelantan , Malaysia during 1995-2002. A 
thorough clinical examination and hormonal analyses were 
performed . A total of 52 samples included were suspected to have 
CAH based on ambiguity of the external genitalia or electrolyte 
imbalances. 
DNA extraction (no n-phenol chloroform 
standard proced ure) 
'/ 
Po lym erase Chain Reacti on (PC R) 
PCR-ASOH (All ele Spec ifi c Ol igonuc leotide 
Hybridization) mutati o nal analys is us ing PCR-
ASOH tec hnique 
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RESULTS 
Figure 1: Presence of PCR product (873 bp) for CYP21 gene 
exon 1-3 using 2.0% agarose gel electrophoresis. Lane M : 
100 bp DNA ladder, lane N : negative control, lane. 1, 2 : 
norma l samp les, lane 3,4,5,6 : samples showing PCR 
amplifi cation products for CYP21 gene . 
2 , 
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Figure 2: Dot blotting was performed using 1 IJ9 genomic 
DNA. Th e blot was hybridized with 100 pmol/m I of th e 
digoxigenin labeled antiphosphatase (DIG-AP) specific probe 
from samples of patient 1-7. ASOH of PCR product from CAH 
patients was performed with th e probe corresponding to the 
site ex on . The status N: normal, P: patient. 
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Figure 3: Pro30Leu hybridization DNA samples. Dot blotting 
was performed using 1 J.19 genomic DNA. The blot was 
hybridized with 100 pmol /ml of the digoxigenin labeled 
antiphosphatase (DIG-AP) specific probe Pro30Leu. ASOH of 
PCR product from CAH patients was performed with the probe 
(Pro30Leu) corresponding to the site exon 1. The status N: 
normal, P: patient. 
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Table 1 
Birth Weight 
(kg) 
Age 
Clinical 
Picture 
Sodium 
135-150 
mmoi/L 
Patient I 
4.2 
32 days 
Adrenal 
, crisis 
Default 
follow up 
CPP 
Mental 
Retardation 
120 
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Patient_U ... l Patient Ill- l Patient·IV. -Pati-ent V 
4.3 3.0 3.3 2.8 
81 days 2 months At birth 10 weeks 
. .. ........ _ ...... ................................. !, ..... ·- .................... _ ................................. _ .. __ ... r- ....................... _ ............... -....... -... _ ....... r-·--.. ----·-----·-----·--·· .. .. 
! 
· Failure to 1 Haematuria ! Normal male i Failure to 
: thrive i Salt.loss 1 external : thrive 
: Normal male I Normal male ! genitalia Ambiguous 
· external ! external I Both testes genitalia 
genitalia ! genitalia ! descended Phallus 2 em 
Both testes i Both testes I Hypoglycae- Single orifice 
descended , descended I mia at its base 
Sepsis, ' No palpable 
meningitis & ! gonads 
adrenal 1 
crisis 
..... , .... 
110 .I 
,• i 131 92 119 
! 
f 
I 
Patient' VI 
2.7 
6 days 
: Neonatal 
, jaundice 
Ambiguous 
genitalia 
Prominent 
i phallus . 
. Single orifice 
at its base 
: No palpable 
:gonads 
· Registered as 
male 
Reassigned as 
female 
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Potassium 
(3.5- 5.0 
mmoi/L) 
Blood urea 
(1.4-6.8 
mmoi/L) 
HC03 
(18- 25 
mmoi/L) 
17-0HP 
(ng/ml) 
Cortisol 
(nmoi/L) 
Patient I P a tie r11:·. IFf.T- r··-··Patfe.nt--iiT··.···· ! .. ~ PatfE;"il·t-IVJ;· r·---~iiati(;-ilf\/ -······Patieni~vr· ...... 
·.: I ·. \ -·.. . ~ . < · ... 
; 
4.3 4.2 6.5 6.6 7.4 8.2 
- .......... -·--~----. ·-·------~---·-- --.. ----~- .... _____ .. ·-·· ,_ .. __ ._ .. ____ .... --------·-- ~------·---·--···~-- --~---· 
I 
28.8 23.0 NA 3.5 NA NA 
.......... - .. -·-------
4
•• ,. • _, .......... ~···· ·-·--····-··-'"·-··-----···-··· r·-·-·-------... -· .. -.. _ .. , __________ ,,. ......... ~ .............. ________ ,._ .. , r···--···-------.. - ............ r------------------·-··-···· 
1.6 4.4 
NA NA 
48 329 
(139-501) . (138-690) 
NA 
9.9 
(0.07 -1.7) 
609 
(140-500) 
NA 
NA 
650 
(138-690) 
NA 
>20 
(up to 1.1 ) 
484 
(139-501) 
NA 
33.2 
(0.7-2.5) 
NA 
I 
I 
I 
I 
I 
.. 
I 
I 
I 
I 
I 
I 
I· 
I 
I 
I 
I 
DISCUSS-ION 
Majority of the mutations in the CYP21 gene in our patients 
are Val281 Leu and Pro30Leu. These mutations were 
reported to result in 20-60% of normal enzyme activi~ and 
both are associated with the non-classical form of CAH ·7 . 
In our study, we found that 3/52 patients (5.7°/o) have 
Val281 Leu while 2/52 patients (3.8°/o) have Pro30Leu 
respectively. -No mutations were observed in lle172Asn. 
Patients with Val281 Leu presented with adrenal crisis during 
infancy and were classified as salt wasting. Two patients 
with Pro30Leu mutations have normal male external 
genitalia . and presented with hyponatraemia and 
hyperkalaemia. We did not identify any patient with .1172N 
mutation which is kno.wn to result in clearly reduced 
enzymatic activity. About 1-2°/o of 1172N mutation is usually 
associated with the SV form 8· 9 . 
Our findings showed· that patients with Pro30Leu mutations 
were associated with non-classical form of CAH whereas 
Val281 Leu mutations were associate~ with salt wasting form 
of CAH. 
CONC·LUSION 
This study suggested that phenotypes are not always 
concordant with the genotype in patients with Val281 Leu 
mutations diagnosed with CAH. 
' 
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Testosterone 
(0.42-0.72 
nmoi/L) 
SRY gene 
US pelvis I 
abdomen 
Mutation in 
CYP21 gene 
Patient I 
1.4 
46,XY 
Present 
... .... 
Patient II l Patient Ill · · .... Fl'atfe.nt-1\( · \" ·:TI?.ail~n·r\' ·.. :--:~:-~,atie·rifvr:>. .. \ 
. . ..... ........... . .... - ..•.... _,,,. .. , ....... _. --· ····- ..... ---··-·· ···------·- -·····-. ·-·-· ........... - i·········---·--·-·····------.. ·-------.. ---·--·-.. r·------·---- ..... ---.-- .. -r---· .. ··--·-.. ~-·----- ... -·-···-·~-- --··---- i 
NA 
46,XY 
Present 
l 
t 
4.9 
I i 
i I 13.3 I NA NA ! 
I ! i : i I 
I I i J 
I ' 
[ ~ 
! 
... --·· .. ~----- .. -·----~ -~-- ... - ........... . ; ·-~ .. --. -~--- ... -··· -----------~-------- .. ·-···-···---. r------·--------. . . . .................. --·----·--------.. -----------------.. - ~ 
I I I 
46,XY I 46,XY II 46,XX 46,XX Iii' 
Present ! Present Not present l Not present 
·-------···-. :··· ........ r·· .. -.---------·----~ 
i l Uterus & Uterus & 
ovaries · ovaries 
! 
o#·•·•--••••~-·••• ••·• , .... ,, ~· O• , .. , ··--··-··------·-
! 
! 
Val281 Leu Val28.1 Leu Pro30Leu Pro30Leu Val281 Leu Gln318Stop 
....... L·-·-··----.. ----·-------·-·---·----·-···· .... ·---------··-· . . . ..: .... ·------·-···-.. ··--·---------'~ 
NA: Not available, CPP: central precocious puberty 
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Molecular Analysis in the management of Congenital Adrenal Hyperplasia (CAH) and 
Ambiguous Genitalia 
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Patients presenting with ambiguous genitalia (AG) often pose a dilemma to the attending 
clinicians with regard to sex assignment. To avoid gender confusion in later life, it is 
important to recognize the underlying ca use, initiate treatment and appropriate sex 
assignment as soon as possible. We present 3 case reports to illustrate the use of 
fluorescence in-situ hybridization (FISH), chromosome karyotyping and SRY gene 
identification in the evaluation of pati ents with AG. Cm;rent hormonal and imaging 
studies for sex determination could be complemented by the application of chromosomal 
and molecular genetic studies which provide rapid and reliable genetic diagnosis. Delay 
in diagnosis .and treatment may result in death due to undiagnosed adrenal crisis in case 
of congenital adrenal hyperplasia (CAH) and wrong sex assignment with its tragic 
consequences. Molecular study and determination of the SRY gene are additional tools 
for the investigations of palicnts with AG and intersex disorders. 
Key words: congenital adrenal hyperplasia (CA l·/), ambiguous genita lia (A G), sex 
determination region-Y (SRY). 
INTRODUCTION The word ambiguous means indeterminate, 
doubtful or uncertain. The term ambiguous genitalia 
(AG) describe external genitalia that do not conform 
to that of male or female. This would include severe 
hypospadias with or without palpable gonads or 
micropenis 1• Other description for such 
abnormalities include enlarged phallus/cli toris 
scrotali sation of the labioscrota! folds, partial 0 ;. 
complete fusion of the labioscrotal folds, chordee 
urogenital sinus and blind vaginal pouch. ' 
The issue of gender assignment causes anxiety 
and the problem of acceptance on th~ p~rt of the 
parents. Patients with ambiguous gemtalJa sh o~l!d 
be investigated in order to understand the underl y111g 
pathology ·and to provide a ra tio~a l ap~r~ac ~1 to 
management and sex assignment. DtagnoSIS ts mcled 
by hormonal, ~1ag ing .s t.udies a nd genetic 
inform ation. Current clwi cal and hormona l 
investigation protocols for sex determination can be 
enhanced by the application of chromosomal and 
molecular genetic studies using SRY gene. 
12 
. The problem in the management of a baby with 
A~ IS not ~n.ly sex determination and appropriate 
assignment, 1t IS also prompt recognition of underlying 
\, 
!: 
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Molecular Anoly.vi.v in tile lllllllllg<·met/1 ,1· Congenital Adrenal Nyperpla.via (CAN) and Ambiguous Genitalia 
medica l emergencies that may be associated. The 
clinician must must be quick to detect life-U1reatening 
adrenal crisis in case of salt losing congenital adrenal 
hyperplasia (CAH)2 , and initiate immediate 
investigations and management3.7 
The initial treatment goals include firstly, 
determination of the appropriate sex of rearing as quickly 
as poss ible. Secondly, establishment of defini tive 
diagnosis, which may take longer to achieve. To avoid 
gender identificati on crisis, social , personality and 
religious problems during adulthood, follow up care and 
management is needed to ensure physical and 
psychological development concordant with the assignee! 
sex4 . 
Availability of specific hormonal investigation 
is limited. Conventionally, genetic sex is determined by 
chromosome karyotyping. The result is generall y 
available within one month but a preliminary report may 
be available within a week. Cun·ently new methods are 
available using molecular technology such as 
fluorescence in-situ hybridization (FISH) using the X 
(Figure 7) and Y (Figure 8) probes to identify the types 
of chromatin present. Identification of SRY gene (Figure 
9) is another of these new molecular- techniques 4 . 
Figure 7: Microphotography of FISH technique using 
I he chromosome X probe (pDMX 1) on in1erplwse cell, 
c11.,-0 w shows 2 signals of the chromosome X 
The SRY gene is the testis-determining gene 
located on the short arm of the Y chromosome. It 
ini tiates a cascade of events that ultimately lead to 
testis di ffere ntiation. Studies sho~ed that SRY gene 
in an individual indicates the presence of testicular 
ti ssues. The use of the SRY gene testing as a tool in 
complementing hormonal, imaging studies in the 
evaluation of children with AG is helpful. The result 
can be obtained in less than a week 4 • Decision on 
gender ass ignment and registration of birth of baby 
can be made without much delay. 
Figure 8: Mil.:ropho1ography of FISH technique using 
pH Y I probe. Arrow shows I he specific Y chromosome. 
Figure 9: Photograph of amplified multiplex PCR products 
using X, Y chromosome and SRY gene specific PCR primers. 
M- 100 bp DNA ladder (marker) 
I - DNA sample ji'Orn 46 XY wi1h the presence ofSRY gene 
(273 bp) 
2- DNA SWJtplejimn 46 XX in the absence o~' 1he SRY 
. 1 gene 
3 - DNA .1·anzp!e from 46 XY with the absence of SRY ene 
4- Negwive control (wilhout DNA) g 
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OBJECTIVE 
The aim of the study is to apply the molecular 
studies to compleriient the investigations for the 
· genetic assignment of patients with ambiguous 
genitalia by presenting 3 case reports. 
METHODS 
Three patients were referred to Hospital Kota 
Bharu (HKB) and Hospital Universiti Sains Malaysia 
(HUSM) for further management of ambiguous 
genitalia. Blood specimen of3-5 ml from the patients 
with ambiguous genitalia was collected in sodium 
EDTA or lithium heparin cqntainer. Blood was 
cultured for metaphase cells for cytogenetic and 
FISH according to the standard protocoL Genomic 
DNA was extracted and subjected to the PCR 
analysis of SRY gene method5• 6• 
RESULTS I 
Patient 1, presented to Hospital Kota Bharu 
(HKB) at 10 weeks of age with intermittent vomiting 
and failure to thrive since birth. The patient, a product 
ofa non-consanguineous marriage was born full term by 
spontaneous vaginal delivery at a district hospital with a 
birth weight of2.8 kg (25-50111 percentile), length 56 em 
(>971h percentile) and head circumference 33 em ( 10-
251h percentile). She is the youngest of 5 siblings and the 
eldest sibling who was a boy died at 17 days old of an 
unknown cause. On examination she was mildly 
dehydrated with a weight of 2.8 kg ( <3rd percentile). She 
was afebrile and the blood pressure was 60/40 mmHg. 
No other abnormalities were detected apart from AG 
with a prominent phallus measuring 2 em. No gonads or 
rugae were noted at the labioscrotal folds, which was 
not hyperpigmented. There was a single orifice at the 
base of the phallus. The baby was registered as a girl by 
the parents as they were not aware of the ambiguity of 
the external genitalia at that particular time. 
The initial electrolytes showed 
hyponatraemia, hyperkalaemia, increased blood urea 
and metabolic acidosis (Table 1). A diagnosis of salt-
losing CAH was made and she was started on 
glucocorticoids and mineralocorti'coids. The 
hormonal investigations showed that 17-
hydroxyprogesterone ( 17 -OHP) and aldosterone 
were elevated with normal cortisol level (Table 1). 
The results of hormonal investigation of the 3 patients are tabulated as follows: 
Tests Nonnal Range 
Sodium 135-150 mmol/L 
Potassium 3.5-5.0 mmoi/L 
Blood urea 1.4 6.8 mmoi/L 
Standard 18-25 mmoi/L 
bicarbonate (HC03) 
17-0HP 
Cortisol 
ACTH 
Testosterone 
Aldosterone 
Plasma renin 
activity 
Karyotyping 
SRY gene 
Ultrasou'bd 
Genitogram 
Table 1: **Results obtamed p1wr to homwnal therapy 
14 
Patient 1 Patient 2 Patient 3 
92 118 
138* 
7.4 8.2 5.5* 
11.0 NA 5.7* 
12.0 NA NA 
>20 ng/ml 33.2 nglml 2.8 nmoi/L** 3 mth-5 yr: up to 
1.1 n-g/ml (<0.7-2.5) (normal for age) 
484 nmol/L 67 nmol/L* 
(am : 139-501) NA (am: 221-690 
pm : 110-3451 
ND 50.7 pg/ml ND 
_{N: <37) 
NA <20 ng/dl 
3.0 nmoi/L 
(no reference) adult female: 
0.9-2.8 
>3,300 pmol/L I ,400 pmoi/L* (111-860 NA erect: 11 0-860 pmol/L) supine: 30-440 
NA NA 
72.0 nglmllh* 
erect: 1.3-4.0 
supine: 0.1-2.4 
46,XX 46,XX 46,XX 
Not present Not present Not Present 
Uterus. Bilateral 
Uterus and pelvi-calyceal 
ovaries Uterus system dilatation. 
Mildly distended 
b1adder. 
Figure 3 Figure 5 ND 
* Pattent was on lronnonal therapy N A ·l n: 1101 avm able ND: not done 
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On follow-up she had normal weight gain and 
serum electrolytes. At 2 years of age there was 
evidence of under treatment as there was an 
accele ration in growth velocity. Bone age was 
reported as between 6 to 9 months old. The dose of 
cortisone acetate was increased to 10 mg/m2/day and 
5 months later, it was further increased to 30 mg/m2/ 
day. Serum 17-0HP was monitored. Her bone age 
at 6 years old was reported as 5 years and 10 months. 
The blood pressure was normal except fo r a 
borderline reading of l 20170 mm Hg at 4 6/12 and 
5 6112 years old. 
At 6 5/12 years old, she was admitted to our 
centre for fever, vomiting and 3 episodes of fits . 
Patient had hypote nsion and needed assi s ted 
ventilation. She was managed as adrenal cris is and 
meningitis' (Figure 1). Her height was 110 em (25-
50th percentile), weight 20 kg (75-90th percentile). 
She appeared muscular with hypertrophied clitoris 
measuring 3.2 em (Figure 2). During the course of 
admission she was noted to have hypertension that 
was initi all y attributed to the high d ose of 
intravenous hydrocortisone. 
An echocardiography performed revealed a 
thi ckened left ventricular w all wi th reduced 
contractility. Patient was thought to have a long-
standing hyperte ns ion. She was sta rted on 
antihypertensives and digoxin. Fludrocortisone was 
di scontinued. The results of molecular s tu dies 
showed a genotype of 46, XX and SRY gene was 
not present. Ultrasound of the abdomen and pelvis 
showed female internal reproductive system . 
On follow-up, the serum electrolytes without 
mineralocorticoid therapy were normal. Genitogram 
of patient 1 (Figure 3) showed opacification of both 
the bladder and vagina. The perineal opening 
continued into a short segment urogenital sinus that 
bifurcated just at the level of inferior pubic rami. 
C li toroplas ty and vaginoplasty were performed. 
Patient was maintained on glucocor(icoids at a dose 
of 16 mg/m2/day and her blood pressure readings 
were normal. 
Patient 2, was born full term by spontaneous 
vaginal deli very at a district hospital with a birth 
weight of 2.7 kg (25'h percentile). He was registered 
as a boy at birth. On day 6 of life, he was referred to 
HKB for severe neonatal j aundice tha t requ ired 
intensive phototherapy. Patient is the younger of 2 
s iblings and a product of a consanguineous marriage. 
During hospita lization, i t was noted that 
patient had an AG de~cribed as a promi~ent ph~llus, 
hyperpigme nted labiOscrotal folds wtth a s togie 
orifice at the base of the phallus and gonads were 
not palpable. Initial serum electrolytes showed severe 
Figure 1: CT scan of patient 1: Presence of meningeal 
enhancement on the right temporo-parietal region 
suggestive of meningitis. 
Figure 2: External genitalia of patiefll 1: Enlarged clitoris 
of 3.2 em. · 
Figure 3: Genitogram of patient 1: The urinary bladder 
( UBD) and vagina ( V) are opacified with a single perinecil 
opening. 
hyponatraemia and hyperkalaemia, Based on the 
c ~i nica l_ pic ture and e lec trol yte abno rmality a 
dtagnosts of CAH was made. Patient was started 0 11 
g lucocorticoid and mineralocortico id Hor 1 . mona 
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investigations showed elevated 17-0HP and ACTH 
level. The testos terone was <20 ng/dl. Chromosome 
analysis showed a 46, XX karyotype and SRY gene 
was hot present. The ultrasound of abdomen and 
pelvis revealed the presence of a uterus (Figure 4) 
and the genitogram demonstrated a normal urinary 
bladder (Figure 5). Patient was re-assigned as female 
at the age 6f 6 months. Patient was first seen in our 
centre at the age of 9 months. Weight was 6.4 kg 
(10-25th percentile), height 64.3 em (50th percentile) 
and head circuinference 42.5cm (25-50th percentile). 
The external genitalia was hyperpigmented over the 
labia majora. Gonads were not palpable. The clitoris 
measured 2.5 em wi th a single orifice at its base. 
S ubsequent 17-0HP and testosterone level was 
su-ppressed while on treatment. Further surgical 
intervention was pl.anned. 
Patient 3 was referred to our centre on Day 13 
of life for further management of AG. Patient was born 
full term by spontaneous vaginal delivery at a private 
hospital with a birth weight of 3.1 kg (75'h percentile). 
The parents are non-consanguineous and patient has 
an elder s ister who is healthy. Mother had a 
miscarriage for the first pregnancy. On Day 5 of life 
patient had hyponatraemia and hyperkalaemia. Based 
on the clinical finding of ambiguous gen italia and 
typical electrolyte changes, diagnosis of CAH was 
made. Treatment was started with glucocorticoids and 
mineralocorticoids after performing some hormonal 
investigations. Ultrasound of the abdomen reveal ed 
bilateral large adrenal g lands and presence of a uterus. 
On exami nation, the weight was 3.3 kg (75-
90'h percentile) and length 52 em (>97111 percentile). 
Baby had oral thrush and .greenish discharge from the 
umbilicus. The external geni talia appeared feminine 
with a clitoris measuring 0.9 em in length. There was 
s light hyperpigmentation and scrotalisation of the 
medial aspect of the labia majora. Gonads were not 
palpable. There was no fusion of the labia minora and 
there wete 2 slit- li ke orifices seen representi ng the 
urethra and vaginal orifices. The electrolytes while 
patient was on hormonal therapy showed normal 
serum sodi um and blood urea level with s li ght 
hyperkalaemia (Table l ). 
Patient was maintained on glucocorticoids and 
mineralocorticoids pending results of hormona l 
investigations. A repeat ultrasound examination at our 
centre showed presence of uterus, normal suprarenal 
glands, dilatation of the pelvicalyceal system of both 
kidneys. (Figure 46) and mildly d istended ur inary 
bladder. The urine examination was normal and no 
organisms were cultured. Umbilical swab showed a 
mixed growth of Gram negative organism and the full 
blood picture showed reactive thrombocytosis. The 
16 
Figure 4, US pelvis ofpatient2 showing the uterus (UT), 
urinary bladder (UBD) 
Figure 5, Genitogram of patient 2, The urina1y bladder 
( U BD) was filled with contrast and normal in outline. 
F~gure 6, Ulll:asound of the kidneys of patient 3 showing 
btlateral pelvtcalyceal system dilatation (circle). 
serum testosterone level was slightly elevated according 
to the adult female range. Serum 17-0HP level before 
commencement of hormonal the rapy was normal. 
A l~osterone and plasma renin activi ty obtained when 
patient was on mineralocorticoid therapy were s till 
elevated for age. Molecular studies confirmed U1at patient's 
karyotype was 46 XX, SRY gene was not present. 
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Moleculctr Ant~lysi:.· in tht! llltlltagement of Congenital Adrenal Hyperplasin (CAfl) and Ambiguous Genitalia 
Based on the results of investigations, the 
glucocorticoids and mineralocorticoids were gradually 
tapered and discontinued respectively. On follow-up, 
the clitoris size normalized and the rugation of the 
medial aspect of the labia majora disappeared. 
Subsequent electrolytes values were within the normal 
range. A repeat ultrasound of the urinary system one 
month .later was reported as normal. 
DISCUSSION 
The presentation of the 3 patients illustrates 
the problem encountered in managing AG/CAH. The 
diagnosis of CAH has to be suspected from the 
physical appearance, symptoms or positive family 
history. Investigations have to be done to confirm 
the diagnosis of CAH and the genetic sex of the child. 
Delay in diagnosis and treatment of CAH lead to 
the development of life threatening adrenal crisis as 
in patients 1 and 2. Wrong gender assignment has 
tragic consequences8• In a newborn baby with AG 
urgent investigations are warranted. Sex assignment 
should not be attempted based on appearance of 
external genitalia. Patient 2 was wrongly assigned 
as male and family had to suffer the psychological 
trauma of re-assignment as female at the age of 6 
months. Genetic sex of the 3 patients were 
subsequently established using karyotyping and 
determination of SRY gene9• 
Congenital adrenal hyperplasia was suspected 
in patient 3 based on some ambiguity of the external 
genitalia and electrolyte imbalances at the initial 
presentation. After the relevant hormonal 
investigations were taken, patient was started on 
glucocorticoids and mineralocorticoids by the 
attending paediatrician so as to prevent possible 
adrenal crisis. There was elevated aldosterone level 
and plasma renin activity despite treatment. The full 
blood picture showed thrombocytosis and an umbilical 
swab showed a mixed growth of gram negative bacilli 
suggestive of possible infection. Urosepsis was ruled 
out from the urine examination and culture. In view 
of bilateral pelvicalyceal system dilatation and mildly 
distended urinary bladder, a vesicoureteric reflux and 
urinary tract infection were considered as possible 
causes. However we could not confirm vesicoureteric 
reflux on repeat ultrasound a month from presentation. 
Infection probably causes unresponsiveness of the 
distal renal tubules to aldo~terone, a condition known 
as pseudohypoaldosteronism 10' 11 • 
Imaging studies as ultrasound (US), computed 
tomography (CT) scan and magnetic resonance 
image (MRI) of the abdomen/pelvis can aid in 
identifying the uterus (Figure 4) and gonads. The latter 
however may not be easily visualised. Genitogram 
needs to be done to identify the anatomy of the 
genitourinary system (Figure ~d 5) that is important 
for future surgical correction of the external genitalia. 
Clitoroplasty is usually performed in infancy but not 
performed in patient I due to poor understanding of 
the condition by the parents. Vaginoplasty with division 
of the fused labial folds can be delayed until puberty. 
Close regular evaluation and dosage adjustment 
. of hormonal treatment especially glucocorticoids is 
needed for a successful treatment. Under dosage of 
glucocorticoids cause virilisation while over dosage 
causes hypertension (patient 1) and short stature as an 
adult. 
CONCLUSION 
Molecular studies for SRY gene is one of the 
tools for sex confirmat~n in addition to honnonal and 
imaging studies in the evaluation of AG. Detennination 
of SRY gene may be helpful in sex determination and 
gender assignment. It is a rapid and reliable technique 
and will help the clinicians in making the right 
management decision. Regular medical assessment and 
monitoring of treatment is the key to the successful 
management of CAH/AG. · 
Molecular studies have eriabled us to confirm 
the sex of the 3 patients presenting with AG. It has aided 
us in family counseling and further management 
including the surgical correction of the external genitalia 
as in patient 1 and 2. Furthermore we could counsel 
the parents with regards to sex reassignment in our 
second patient and prevent future virilisation and gender 
crisis. As for patient 3, we were able to counsel the 
parents who are anxious about the true gender of their 
baby and the fact that she need not receive life-long 
hormonal therapy. In the 3 patients that we managed, 
the parents were content to have the problem reetified, 
better understanding of the condition and to accept the 
appropriate management. 
In our experience with the cases of AG, we noted 
that hormonal investigations should be done to conflfm 
CAH and to include the molecular analyses as a 
complementary tool in the battery of investigations. 
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DETECTION OF POINT MUTATION (Pro30Leu) in 
EXON 1 OF THE 21-HYDROXYLASE GENE 
(CYP21) IN PATIENT with CONGENITAL 
ADRENAL HYPERPLASIA USING DIGOXYGENIN 
SYSTEM 
Y.K.Muhamad1, Fuziah MZ2, Rus Anida A3, M.Ros Sidek.1, 
S.F.Ramli1,N.Adam1, M.N.Isa1 
1 Human Genome Centre, 2 Paediatric Department, 
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Congenital adrenal hyperplasia 1s an 
autosomal recess1ve disease with a wide 
range of clinical manifestations. Deficiency 
of the 21-hydroxylase is the most comrnon 
form of congenital adrenal hyperplasia, 
accounting for over 90°/o of cases. The aim 
of the study is to detect the presence of 
point mutations using specifi c probe P30l 
in exon 1 of CYP21 gene. Point mutations 
were studied using the PCR-ASOH Allele 
Specific Oligonucleotide Hybridization) 
technique with Digoxigenin (DIG) system. 
The Pro30Leu(P30l) rnutation is associated 
with electrolyte disturbances vvas found in 2 
patients out of 30 patients . The P30L 
mutation might cause electrolyte 
irrtbalances during neonatal periods that 
subsequently nonnalize without hormonal 
replacement therapy. 
Key Words: Congenital adrenal hyperplasia, ASOH (Allele Specific 
Oligonucleotide Hybridization). 
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Deficiency of the 21- hydroxylase (21-0H) is the most 
common form of congenital adrenal hyperplasia 
(CAH), accounting fo r over 90°/o of cases. This 
enzyme deficiency resu lts in a reduced ability to 
synthesize cortisol and aldosterone, leading to 
increase secretion of adrenocorti cotrophi n (ACTH), 
which causes hyperplasia of the adrenals and an 
increase in androgens 2 . Three different clinical 
phenotypes is described: which includes the salt 
wasting (SW), simple virilizing (SV) and the non 
classical (NC) forrn. The 21-hydroxylase gene 
(CYP21) is located in chromosome 6p 21.31 . 
Molecular diagnostic techniques rely on the 
assumption that specific mutation of CYP21 gene 
give rise to the san1e form of CAH expression . PCR-
AIIele Specific Oligonucleotide Hybrid ization (PCR-
ASOH) method can be applied subsequently to 
identify point mutations in the arnpfified CYP21 
gene3, with using specific probe Pro30Leu (P30L) to 
detect in exon 1 of CYP21 gene. P30L mutations are 
associated with the simple vi r ilizing or non-classical 
form of CAH . 
AI 
To detect the presence of point mutat ions 
using specific probe P 30 Lin exon 1 of CYP21 
gene . 
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73 blood samples were obtained from patients and their families referred 
to Hospital Universiti Sains Malaysia, Kelantan. A thorough clinical 
examination and hormonal analyses \Hre performed. A total of 30 
s<'l mples included were suspected to han CAH based on ambiguity of the 
ex ternal genitalia or electrolyte imbah1nces. The other samples were 
obtained from parents and patients siblings whenever possible. 
DNA extraction 
(non-phenol chloiOform standard procedure) 
Polym.e~ase Ch.ain R.eact~o.n(PCR) N y 
1t~~l;m111l!Gn"~ .. ~~~J 
PCR-ASOH (Allele Specific Oligonucleotide 
Hybridization) technique with Digoxigenin (DIG) 
system. 
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Presence of PCR product (873 bp) for CYP21 gene exon 1-3 using 
2.0 % agarose gel electrophoresis (see figure 1 ) . 
Figure 1: Lane M is a 100 bp DNA ladder, lane N is negative control, lane 1 ,2, are 
normal sample and lane 3,4 ,5,6 sample showed PCR amplification products for 
CYP21 gene . 
The presence of P30L mutations, which have been establ ished to be the cause of 
complete or partial 21- hydroxylase enzyme inactivation, was analyzed by PCR -
/-\S.OH using DIG system in 30 patients with ambiguous genitalia as well as in 43 
family members 
P1 F1 M1 P2 F2 M2 
Figure 2: 
Dot blotting was performed using 1~g genomic DNA. The blot was hybridized 
with 100 pmol/ml of the digoxigenin labeled antiphosphatase (DIG-AP} specific 
probe P30L. ASOH of PCR product from CAH patients or parents, with P30 L 
corresponding to the s ite exon 1 .The status P: Patient, M: Mother, F: father. 
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The Pro30Leu m\.Jtation is associated with electrolyte 
disturbances was found in 2 patients out of 30 patients. 
Patient I, fullterr)) delivered by emergency Caesarean 
section due to bleeding placenta praevia. Baby was 
admitted to the n~onatal intensive care unit for transient 
tachypnoea of the newborn. Examination of the genita lia 
was normal ma l~ with both testes descended in the 
scrotum. Initial el~ctrolvtes shov.1ed hyponatraemia · and 
J 
hiperkalaemia with normal serum cortisol level. On follow-
up patient was 9qining weight with normal electrolytes. 
Patient II presented . at the age of 2 months with 
hyponatraemia antf hyperkalaemia. There v1as a normal 
male external genital ia with both testes descended. He was 
treated with sodiutn chloride and fludrocortisone. In both 
patients, there wa~ no ambiguity of the external genitalia 
and both have salt loss. However the salt loss only require 
short term replacement therapy with sodium chloride and 
fludrocortisone in Patient 11 and no treatment in patient I. 
We would like to hypothesize that P30L mutation might 
cause electrolyte imbalances during neonatal period that 
subsequently nonl1alize without hormonal replacement 
therapy. From the tlarents' results, we observe that P30L is 
present in the mother whereas P30L is present in one of 
the fathers of both patients. We need to study more 
patients to be able to conclude a similar finding . 
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MOLECULAR ANALYSIS IN GENDER 
ASSIGNMENT AND MANAGEMENT OF 
AMBIGUOUS GENITALIA 
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Patients presenting with ambiguous genitalia (AG) 
often pose a dilemma to the attending clinicians as to 
definite sex assignment. To avoid any doubt about 
gender of rearing it is necessary that correct 
diagnosis is made within a short period of birth. 
Current hormonal and imaging studies for sex 
determination could be supported by the application 
of chromosomal and molecular genetic studies using 
the SRY gene. Delay in diagnosis and treatment of 
congenital adrenal hyperplasia (CAH) lead to adrenal 
crisis. Moreover inappropriate gender assignment has 
tragic consequences. Clinicians must be aware as 
well that pseudohypoaldosteronism can masquerade 
as CAH and causes inappropriate hormonal therapy. 
The SRY gene complements the investigations and 
has aided us in patient management and counseling 
of parents. In the near future we are proceeding to the 
analysis of the CYP21 gene to confirm diagnosis of 
CAH due to 21- hydroxylase deficiency. 
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The issue of correct gender assignment causes some. 
amount of anxiety and the problem of acceptance on the 
part of the parents. Patients with ambiguous genitalia 
should be investigated for definite. sex assignment. 
Diagnosis will be aided by hormonal, imaging studies 
and genetics information. Current clinical and hormonal 
investigation protocols for sex determination could be 
supported by the application of chromosomal and 
molecular genetic studies using SRY gene as one of the 
tools for gender assignment. 
..... 
To apply molecular studies to complement 
investigations for the genetic assignment of patient with 
ambiguous genitalia. 
'nTl~~~ ~.~r;tt *'~•• ... ~w 
Three patients were referred to Hospital Kota Bharu 
(HKB) and Hospital Universiti Sains Malaysia (HUSM) 
for further management of ambiguous genitalia. 3 - 5 
ml blood specimen from the patients with ambiguous 
genitalia was collected in sodium EDTA or lithium 
~heparin container. Blood was cultured for metaphase 
cells for cytogenetic and FISH (Fluorescence in situ 
hybridization) according to the standard protocol. 
Genomic DNA was extracted and subjected to the 
PCR analysis of SRY gene using modified method 
described earlier (1,2). 
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Table 1 
Tests/Patient I II 
Sodium 92 118 135-150 mmolll 
Potassium 7.4 8.2 3.5 - 5.0 mmolll 
>20 33.2 17-0HP 3 mths-5 yrs: 
up to 1.1 ng/ml (<0.7-2.5) 
Cortisol 484 NA 
am :139-501 
ACTH NO 50.7 pg/ml (N: <37) 
<20 Testosterone NA (ng/dl) 
>3,300 
Aldosterone {111-860 NA 
pmoi/L) 
PRA NA NA 
Karyotype 46,XX 4s·,xx 
SRYgene Not present Not present 
Uterus and US pelvis/abdomen Uterus 
ovaries 
Genitogram Figure 2 Figure 3 
* results from overseas 
**patient was on glucocorticoids and mineralocorticoids 
NA: not available; ND : not done 
Ill 
138** 
5.5** 
2.8 nmolll* 
{normal for age) 
67 nmoi/L 
(am: 221-690) 
NO 
3.0 nmoi/L 
adult female: 0.9-2.8 
1 ,400 ·pmoi/L * 
erect: 11 0-860 
supine : 30-440 
72.0 ng/ml/h 
erect: 1.3-4.0 
supine:0.1-2.4 
46,XX 
Not present 
Uterus. Bilateral pelvi-
calyceal system 
ktilatation. Mildly 
ktistended bladder . 
Not done 
PT AGE SEX 
I 10 w F 
II 6 d M 
9m F 
Ill 13 d F 
CLINICAL FEATURES DIAGNOSIS 
Failure to thrive. Adrenal crisis. CAH, salt loser 
AG: phallus 2 em, 
no gonads palpable, no rugae, 
no hyperpigmentation, single 
orifice at base of the phallus. 
Severe neonatal jaundice. AG: CAH, salt loser 
prominent phallus, 
hyperpigmented labia-scrotal folds, 
single orifice at the base of 
phallus, no gonads palpable. 
Reassigned as female. 
Clitoris measures 2.5 em 
AG: clitoris 0.9 em 
Slight hyperpigmentation and 
scrotalisation of the medial aspect 
of the labia majora. No palpable 
gonads, no fusion of ·labia minora, 
2 slit-like · orifices seen. Mild 
enlargement of adrenal glands. 
P seudohypoal-
dosteronism 
THERAPY 
Gand M 
Gand M 
Gand M 
COMPLICATION I PROGRESS 
Undertreatment and poor compliance 
caused virilisation, Patient was put 
on high dose of glucocorticoids to 
suppress ·virilisation. At 6 years old, 
she had fits and treated as 
meningitis. Had hypertension and ieft 
ventricular hypertrophy. 
Sex reassignment at 6 months old. 
Bilateral pelvi-calyceal system 
dilatation. Mildly distended urinary 
bladder. Both abnormalities resolved 
after one month. Normal electrolytes 
after discontinuation of hormonal 
treatment. Normal repeat US of 
genitourinary system. Normal MCU. 
PT: patient, d: day, w: week, m: months, F: female, M: male, G: Glucocorticoids, M: mineralocorticoids, US: ultrasound, MCU : · 
micturating cystourethrogram 
!- ··~. 
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·~. Pig. 1. ·: External genitalia of patient 
::·.,:,.'¢'nlarged clitoris of 3.2 em. 
.-. 
f l 
Fig. 3 : Genitogram of patient ll, the 
urinary bladder (UBD) was filled with 
contrast and normal in outline 
Fig. 2 : Genitogram of patient I, both the bladder 
and vagina (V) are opacified. Single perineal 
opening with short segment urogenital sinus. 
Fig. 4 : Ultrasound of the kidneys a,f patient Ill : Dilated 
pelvicalyceal system of both kidneys (arrow). 
Mild dilatation of urinary bladder. No adrenal mass seen. 
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Fig. 5 : US pelvis showin.g the uterus (UT) & 
urinary bladder (UBD). 
Fig. 7:FISH withY chromosome 
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Fig . 6:FISH with X chromosome. 
Fig. 8 : Multiplex PCR of X,Y chromosome and SRY gene 
specific reg ions. 
M-1 00 bp DNA ladder , 
1-DNA sample from 46 XY w ith the presence of SRY gene 
2- DNA sample from 46 XX 
3- DNA sample from 46 XY w ith t he absence of SRY gene 
4-negative control ( without DNA ) 
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The presentation of the 3 patients illustrated the problem 
encountered in managing AG/CAH. The dia.gnosis of CAH has to 
be suspected and confirmed through investigations. Delay in 
diagnosis and treatment of CAH lead to development of adrenal 
crisis which can be life threatening (pt.1 & 2). 
Inappropriate gender assignment has tragic consequences. 
In a newborn baby with AG, sex assignment should not be 
attempted until the results of appropriate investigations are 
available. Patient 2 was assigne.d as male at birth but after the 
AG was noted and investigated, patient was reassigned as 
female. Sex confirmation through genetic studies includes 
karyotyping and SRY gene. 
Patient 3 was treated as CAH and relevant hormonal 
investigations performed. From the results of the investigations 
(table 1 ), pseudohypoaldosteronism was suspected. Urosepsis 
was ruled out from the urine examination. However, the full blood 
picture showed reactive lymphocytes, ·thrombocytosis and an 
umbilical swab showed a mixed growth of Gram negative bacilli 
suggestive of a possible infection. Subsequent ultrasound of the 
genitourinary system and electrolytes was normal after cessation 
of hormonal medications. Pseudohypoaldosteronism can 
masquarade as the salt losing type of CAH. 
Imaging studies can aid in identifying the uterus (fig.S) and 
gonads. Genitogram will identify the anatomy of the genitourinary 
system (fig. 2&3), which is important for future surgical 
.-correction. Clitoroplasty was not performed in patient 1 due to 
parents' poor understanding of the importance of surgical 
correction. 
Close monitoring of the patient is needed to ensure that 
virilisation or hypertension did not occur due to under or 
overdosage of hormonal therapy respectively. 
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~· MoJecular studies complement hormonal and imaging 
studies for sex confirmation and appropriate sex assignment · 
or reassignment. Regular medical assessment and. 
monitoring of treatment is the key to the successful 
management of CAH. Pseudohypoaldosteronism is another 
differential diagnosis to be thought of in cases of electrolyte 
imbalances that causes inappropriate hormonal therapy. 
Counseling of the parents is important to avoid 
mismanagement, complication and psychosocial issues. We 
intend to study the CYP21 gene rearrangement to confirm 
diagnosis of CAH in those patients presenting with AG: 
1) Lida T, Nakahori Y, Komaki R, Mori E, Hayashi N. Tsutsumi O, Taketani Y, 
Nakagome Y. 1994. A novel missense mutation in the HMG box of the SRY gene 
in a patient with the XY_ sex reversa l. Human Malec. Genet. 3:1437-1438 
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